Since embelin induced apoptosis in pancreatic cancer cells harboring Kras mutation by suppressing Akt pathway, suggesting its clinical benefits against human pancreatic cancer where Kras is mostly mutated. Here, AKT1 is linked to familial pancreatic carcinoma.